Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Inventory (2020 - 2025)

Historic Inventory for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $21.1 million.

  • Rapid Micro Biosystems' Inventory fell 87.05% to $21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.1 million, marking a year-over-year decrease of 87.05%. This contributed to the annual value of $20.2 million for FY2024, which is 119.73% up from last year.
  • Latest data reveals that Rapid Micro Biosystems reported Inventory of $21.1 million as of Q3 2025, which was down 87.05% from $20.6 million recorded in Q2 2025.
  • Rapid Micro Biosystems' Inventory's 5-year high stood at $21.4 million during Q2 2024, with a 5-year trough of $11.9 million in Q2 2021.
  • Moreover, its 5-year median value for Inventory was $20.6 million (2025), whereas its average is $19.5 million.
  • Per our database at Business Quant, Rapid Micro Biosystems' Inventory surged by 7878.25% in 2022 and then crashed by 578.66% in 2023.
  • Rapid Micro Biosystems' Inventory (Quarter) stood at $15.7 million in 2021, then soared by 35.2% to $21.2 million in 2022, then decreased by 5.79% to $20.0 million in 2023, then grew by 1.2% to $20.2 million in 2024, then rose by 4.3% to $21.1 million in 2025.
  • Its last three reported values are $21.1 million in Q3 2025, $20.6 million for Q2 2025, and $20.7 million during Q1 2025.